Cipla Unclassified
FDA Approved Drugs
Cipla Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 66
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Social Profiles
Company Snapshot
Cipla Unclassified
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra 400 013
India
www.cipla.com/ corporate.one@cipla.com View on MapFDA Approved Drug Records ( 66 records )
Drug Name
ABACAVIR AND LAMIVUDINE
Product Number
1
Dosage Form
-
Strength
120MG;60MG
Approval Date
-
Active Ingredient
ABACAVIR; LAMIVUDINE
Application Number
208775
Product Number
1
Dosage Form
-
Strength
120MG;60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR SULFATE
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
-
Active Ingredient
ABACAVIR SULFATE
Application Number
22547
Product Number
1
Dosage Form
-
Strength
60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR SULFATE
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Active Ingredient
ABACAVIR SULFATE
Application Number
78348
Product Number
1
Dosage Form
-
Strength
20MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR SULFATE; LAMIVUDINE
Product Number
1
Dosage Form
-
Strength
60MG; 30MG
Approval Date
-
Active Ingredient
ABACAVIR SULFATE; LAMIVUDINE
Application Number
202007
Product Number
1
Dosage Form
-
Strength
60MG; 30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Application Number
210391
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
-
Active Ingredient
ABACAVIR, DOLUTEGRAVIR, LAMIVUDINE
Application Number
210391
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
216914
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
216914
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
216914
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
5
Dosage Form
-
Strength
120MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
216914
Product Number
5
Dosage Form
-
Strength
120MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
6
Dosage Form
-
Strength
15MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
216914
Product Number
6
Dosage Form
-
Strength
15MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
218766
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
218766
Product Number
3
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
218766
Product Number
4
Dosage Form
-
Strength
30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
5
Dosage Form
-
Strength
120MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
218766
Product Number
5
Dosage Form
-
Strength
120MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
6
Dosage Form
-
Strength
15MG
Approval Date
-
Active Ingredient
BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Application Number
218766
Product Number
6
Dosage Form
-
Strength
15MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
206288
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
4
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
206288
Product Number
4
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
5
Dosage Form
-
Strength
800MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
206288
Product Number
5
Dosage Form
-
Strength
800MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
207189
Product Number
1
Dosage Form
-
Strength
75MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
207189
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
207189
Product Number
3
Dosage Form
-
Strength
400MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DARUNAVIR
Product Number
4
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
DARUNAVIR
Application Number
207189
Product Number
4
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
209658
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR SODIUM
Application Number
210812
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINE
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
-
Active Ingredient
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
Application Number
210811
Product Number
2
Dosage Form
-
Strength
300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR SODIUM AND ABACAVIR SULFATE AND LAMIVUDINE
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE
Application Number
210811
Product Number
3
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
EFAVIRENZ
Application Number
77916
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
EFAVIRENZ
Application Number
90155
Product Number
1
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
Application Number
204568
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
91593
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
91593
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
-
Active Ingredient
EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
91593
Product Number
3
Dosage Form
-
Strength
300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
Product Number
1
Dosage Form
-
Strength
5MG;1000MG
Approval Date
-
Active Ingredient
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
Application Number
212243
Product Number
1
Dosage Form
-
Strength
5MG;1000MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
Product Number
1
Dosage Form
-
Strength
200MG/25MG
Approval Date
-
Active Ingredient
EMTRICITABINE, TENOFOVIR ALAFENAMIDE
Application Number
211680
Product Number
1
Dosage Form
-
Strength
200MG/25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
EMTRICITABINE; RILPIVIRINE; TENOFOVIR ALAFENAMIDE
Product Number
1
Dosage Form
-
Strength
200MG;25MG;25MG
Approval Date
-
Active Ingredient
EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE
Application Number
214058
Product Number
1
Dosage Form
-
Strength
200MG;25MG;25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product Number
1
Dosage Form
-
Strength
12.5MG; 150MG
Approval Date
-
Active Ingredient
HYDROCHLOROTHIAZIDE; IRBESARTAN
Application Number
201616
Product Number
1
Dosage Form
-
Strength
12.5MG; 150MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HYDROCHLOROTHIAZIDE; IRBESARTAN
Product Number
2
Dosage Form
-
Strength
12.5MG; 300MG
Approval Date
-
Active Ingredient
HYDROCHLOROTHIAZIDE; IRBESARTAN
Application Number
201616
Product Number
2
Dosage Form
-
Strength
12.5MG; 300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
-
Active Ingredient
LAMIVUDINE
Application Number
77980
Product Number
1
Dosage Form
-
Strength
10MG/ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
30MG; 50MG; 60MG
Approval Date
-
Active Ingredient
LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
Application Number
203076
Product Number
1
Dosage Form
-
Strength
30MG; 50MG; 60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; STAVUDINE
Product Number
1
Dosage Form
-
Strength
150MG; 30MG
Approval Date
-
Active Ingredient
LAMIVUDINE; STAVUDINE
Application Number
21974
Product Number
1
Dosage Form
-
Strength
150MG; 30MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; STAVUDINE
Product Number
2
Dosage Form
-
Strength
150MG; 40MG
Approval Date
-
Active Ingredient
LAMIVUDINE; STAVUDINE
Application Number
21974
Product Number
2
Dosage Form
-
Strength
150MG; 40MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; STAVUDINE; NEVIRAPINE
Product Number
1
Dosage Form
-
Strength
150MG; 30MG; 200MG
Approval Date
-
Active Ingredient
LAMIVUDINE; STAVUDINE; NEVIRAPINE
Application Number
21969
Product Number
1
Dosage Form
-
Strength
150MG; 30MG; 200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; STAVUDINE; NEVIRAPINE
Product Number
2
Dosage Form
-
Strength
150MG; 40MG; 200MG
Approval Date
-
Active Ingredient
LAMIVUDINE; STAVUDINE; NEVIRAPINE
Application Number
21969
Product Number
2
Dosage Form
-
Strength
150MG; 40MG; 200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
300MG; 300MG
Approval Date
-
Active Ingredient
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
200623
Product Number
1
Dosage Form
-
Strength
300MG; 300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
30MG; 60MG
Approval Date
-
Active Ingredient
LAMIVUDINE; ZIDOVUDINE
Application Number
201151
Product Number
1
Dosage Form
-
Strength
30MG; 60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; ZIDOVUDINE
Product Number
1
Dosage Form
-
Strength
30MG; 60MG
Approval Date
-
Active Ingredient
LAMIVUDINE; ZIDOVUDINE
Application Number
202814
Product Number
1
Dosage Form
-
Strength
30MG; 60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
Product Number
1
Dosage Form
-
Strength
150MG; 300MG; 200MG
Approval Date
-
Active Ingredient
LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
Application Number
21971
Product Number
1
Dosage Form
-
Strength
150MG; 300MG; 200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LOPINAVIR AND RITONAVIR
Product Number
1
Dosage Form
-
Strength
40MG;10MG
Approval Date
-
Active Ingredient
LOPINAVIR;RITONAVIR
Application Number
205425
Product Number
1
Dosage Form
-
Strength
40MG;10MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LOPINAVIR; RITONAVIR
Product Number
1
Dosage Form
-
Strength
200MG; 50MG
Approval Date
-
Active Ingredient
LOPINAVIR; RITONAVIR
Application Number
90371
Product Number
1
Dosage Form
-
Strength
200MG; 50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
LOPINAVIR; RITONAVIR
Product Number
1
Dosage Form
-
Strength
80MG; 20MG
Approval Date
-
Active Ingredient
LOPINAVIR; RITONAVIR
Application Number
91203
Product Number
1
Dosage Form
-
Strength
80MG; 20MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
MIDAZOLAM
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
-
Active Ingredient
MIDAZOLAM
Application Number
216048
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEVIRAPINE
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
NEVIRAPINE
Application Number
202212
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEVIRAPINE
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
NEVIRAPINE
Application Number
202212
Product Number
2
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEVIRAPINE
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
-
Active Ingredient
NEVIRAPINE
Application Number
207064
Product Number
1
Dosage Form
-
Strength
400MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
OLAPARIB
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
-
Active Ingredient
OLAPARIB
Application Number
219410
Product Number
2
Dosage Form
-
Strength
150MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
PALBOCICLIB
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
-
Active Ingredient
PALBOCICLIB
Application Number
212980
Product Number
2
Dosage Form
-
Strength
125MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
PALBOCICLIB
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Active Ingredient
PALBOCICLIB
Application Number
212980
Product Number
3
Dosage Form
-
Strength
100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RIFAXIMIN
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
RIFAXIMIN
Application Number
219570
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RITONAVIR
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Active Ingredient
RITONAVIR
Application Number
205040
Product Number
1
Dosage Form
-
Strength
25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RITONAVIR
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
RITONAVIR
Application Number
205040
Product Number
2
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SIPONIMOD
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
-
Active Ingredient
SIPONIMOD
Application Number
218228
Product Number
1
Dosage Form
-
Strength
0.25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SIPONIMOD
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
-
Active Ingredient
SIPONIMOD
Application Number
218228
Product Number
2
Dosage Form
-
Strength
1MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SIPONIMOD
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
-
Active Ingredient
SIPONIMOD
Application Number
218228
Product Number
3
Dosage Form
-
Strength
2MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VORTIOXETINE
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
-
Active Ingredient
VORTIOXETINE
Application Number
211085
Product Number
1
Dosage Form
-
Strength
5MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZOLEDRONIC ACID
Product Number
1
Dosage Form
-
Strength
4MG/5ML(0.8MG/ML)
Approval Date
-
Active Ingredient
ZOLEDRONIC ACID
Application Number
78475
Product Number
1
Dosage Form
-
Strength
4MG/5ML(0.8MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Status Breakdown
66 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABACAVIR AND LAMIVUDINE
Application Number
208775
Product Number
1
Active Ingredient
ABACAVIR; LAMIVUDINE
Dosage Form
-
Strength
120MG;60MG
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.